CTDTTIE: Evaluate the Safety and Diagnostic Advantages of Tilt Down Verses Standard Horizontal Colonoscopy Positioning
Study Details
Study Description
Brief Summary
A tortuous sigmoid colon makes colonoscopy difficult. The purpose of this study was to systematically evaluate the diagnostic utility and incidence of adverse events in women using standard horizontal compared to lateral tilt down positioning for colonoscopy.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
N/A |
Detailed Description
This was a prospective, randomized study. Subjects who provide informed consent and present to the offices of Specialists in Gastroenterology for colonoscopy will be randomized in a 1:1 distribution to either left lateral tilt down versus left lateral horizontal positioning to initiate colonoscopy.
Demographic data as well as routine information regarding the colonoscopy was filled out during or at the end of each procedure. In addition, the following parameters were assessed, and compared between groups:
-
Occurrence of complications related or possibly related to the colonoscopy procedure
-
Scope insertion time
-
Pain during and after the procedure
The subjects' participation was limited to the duration of the colonoscopy, which is typically less than 60 min and a follow up by telephone 24 hours later to assess the occurrence of complications.
Study Design
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
Other: Lateral horizontal body position Subjects randomized to receive colonoscopy in the lateral horizontal position, This is the standard position. The other position - tilt down is the intervention |
Procedure: colonoscopy in the lateral horizontal position
colonoscopy in the lateral horizontal position with tilt down
|
Other: Lateral tilt down body position Subjects randomized to receive colonoscopy in the lateral tilt down position |
Procedure: colonoscopy in the lateral horizontal position
colonoscopy in the lateral horizontal position with tilt down
|
Outcome Measures
Primary Outcome Measures
- Number of Participants Who Experience Adverse Events Which Are Related or Possibly Related to the Colonoscopy Procedure [24 hours]
The number of participants who experience adverse events which are related or possibly related to the colonoscopy procedure will be tallied in each treatment arm.
Secondary Outcome Measures
- Time to Full Colonoscope Insertion [30 minutes]
- Pain Related or Possibly Related to Colonoscopy Procedure [24 hours]
Visual Analogue Scale measured 0-4 with zero being no pain and 4 being most severe pain.
Eligibility Criteria
Criteria
Inclusion Criteria:
-
ability to understand and sign consent
-
women and men with a BMI (body mass index) <35 kg/m2
-
age 18 - 90 years
-
no liquids by mouth for ≥2 hours
-
no solid food for ≥8 hours
Exclusion Criteria:
-
inability to provide informed consent
-
morbid obesity (BMI ≥35)
-
pregnancy
-
uncontrolled gastroesophageal reflux disease
-
gastroparesis
-
scleroderma
-
achalasia
-
Crohn's disease
-
ulcerative colitis
-
history of a colon resection
-
Parkinson's disease
-
brain tumor
-
multiple sclerosis
-
ischemic optic neuropathy
-
glaucoma
-
active pulmonary infection
-
liquid intake <2 hours
-
solid food intake <8 hours prior to the procedure
-
intra-procedure findings of a stricture resulting in an incomplete colonoscopy or Boston bowel preparation scores of <6
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | Advanced Endoscopy Center | St. Louis | Missouri | United States | 63141 |
Sponsors and Collaborators
- Specialists in Gastroenterology, LLC
Investigators
- Principal Investigator: Leonard B Weinstock, MD, Specialists in Gastroenterology, LLC
Study Documents (Full-Text)
None provided.More Information
Publications
- BP-1
- Leonard Weinstock, MD
Study Results
Participant Flow
Recruitment Details | Consecutive women presenting to a private endoscopy center for colonoscopy (with or without a preceding upper endoscopy) were offered participation. A computer generated randomization code was used to assign subjects to either TD or LL group. Subjects were blinded to which group they were assigned. |
---|---|
Pre-assignment Detail | morbid obesity, pregnancy, uncontrolled gastroesophageal reflux disease, gastroparesis, scleroderma, achalasia, Crohn's disease, ulcerative colitis, history of a colon resection, Parkinson's disease, brain tumor, multiple sclerosis, ischemic optic neuropathy, glaucoma, active pulmonary infection |
Arm/Group Title | Lateral Horizontal | Lateral Tilt Down |
---|---|---|
Arm/Group Description | Subjects randomized to receive colonoscopy in the lateral horizontal position | Subjects randomized to receive colonoscopy in the lateral tilt down position |
Period Title: Overall Study | ||
STARTED | 88 | 85 |
COMPLETED | 88 | 85 |
NOT COMPLETED | 0 | 0 |
Baseline Characteristics
Arm/Group Title | Lateral Horizontal | Lateral Tilt Down | Total |
---|---|---|---|
Arm/Group Description | Subjects randomized to receive colonoscopy in the lateral horizontal position | Subjects randomized to receive colonoscopy in the lateral tilt down position | Total of all reporting groups |
Overall Participants | 88 | 85 | 173 |
Age (Count of Participants) | |||
<=18 years |
3
3.4%
|
4
4.7%
|
7
4%
|
Between 18 and 65 years |
40
45.5%
|
50
58.8%
|
90
52%
|
>=65 years |
45
51.1%
|
31
36.5%
|
76
43.9%
|
Age (years) [Mean (Standard Deviation) ] | |||
Mean (Standard Deviation) [years] |
55
(12)
|
56
(11)
|
55
(11)
|
Sex: Female, Male (Count of Participants) | |||
Female |
88
100%
|
85
100%
|
173
100%
|
Male |
0
0%
|
0
0%
|
0
0%
|
Region of Enrollment (participants) [Number] | |||
United States |
88
100%
|
85
100%
|
173
100%
|
Outcome Measures
Title | Number of Participants Who Experience Adverse Events Which Are Related or Possibly Related to the Colonoscopy Procedure |
---|---|
Description | The number of participants who experience adverse events which are related or possibly related to the colonoscopy procedure will be tallied in each treatment arm. |
Time Frame | 24 hours |
Outcome Measure Data
Analysis Population Description |
---|
[Not Specified] |
Arm/Group Title | Lateral Horizontal | Lateral Tilt Down |
---|---|---|
Arm/Group Description | Subjects randomized to receive colonoscopy in the lateral horizontal position | Subjects randomized to receive colonoscopy in the lateral tilt down position |
Measure Participants | 88 | 85 |
Number [participants] |
2
2.3%
|
9
10.6%
|
Title | Time to Full Colonoscope Insertion |
---|---|
Description | |
Time Frame | 30 minutes |
Outcome Measure Data
Analysis Population Description |
---|
[Not Specified] |
Arm/Group Title | Lateral Horizontal | Lateral Tilt Down |
---|---|---|
Arm/Group Description | Subjects randomized to receive colonoscopy in the lateral horizontal position | Subjects randomized to receive colonoscopy in the lateral tilt down position |
Measure Participants | 88 | 85 |
Mean (Standard Deviation) [minutes] |
5.5
(1.2)
|
5.2
(1.1)
|
Title | Pain Related or Possibly Related to Colonoscopy Procedure |
---|---|
Description | Visual Analogue Scale measured 0-4 with zero being no pain and 4 being most severe pain. |
Time Frame | 24 hours |
Outcome Measure Data
Analysis Population Description |
---|
[Not Specified] |
Arm/Group Title | Lateral Horizontal | Lateral Tilt Down |
---|---|---|
Arm/Group Description | Subjects randomized to receive colonoscopy in the lateral horizontal position | Subjects randomized to receive colonoscopy in the lateral tilt down position |
Measure Participants | 88 | 85 |
Mean (Standard Deviation) [units on a scale] |
0.36
(0.03)
|
0.28
(0.02)
|
Adverse Events
Time Frame | ||||
---|---|---|---|---|
Adverse Event Reporting Description | ||||
Arm/Group Title | Lateral Horizontal | Lateral Tilt Down | ||
Arm/Group Description | Subjects randomized to receive colonoscopy in the lateral horizontal position | Subjects randomized to receive colonoscopy in the lateral tilt down position | ||
All Cause Mortality |
||||
Lateral Horizontal | Lateral Tilt Down | |||
Affected / at Risk (%) | # Events | Affected / at Risk (%) | # Events | |
Total | / (NaN) | / (NaN) | ||
Serious Adverse Events |
||||
Lateral Horizontal | Lateral Tilt Down | |||
Affected / at Risk (%) | # Events | Affected / at Risk (%) | # Events | |
Total | 0/88 (0%) | 0/85 (0%) | ||
Other (Not Including Serious) Adverse Events |
||||
Lateral Horizontal | Lateral Tilt Down | |||
Affected / at Risk (%) | # Events | Affected / at Risk (%) | # Events | |
Total | 2/88 (2.3%) | 9/85 (10.6%) | ||
Cardiac disorders | ||||
bradycardia | 2/88 (2.3%) | 2 | 0/85 (0%) | 0 |
Respiratory, thoracic and mediastinal disorders | ||||
oxygen desaturation | 2/88 (2.3%) | 2 | 9/85 (10.6%) | 9 |
Limitations/Caveats
More Information
Certain Agreements
All Principal Investigators ARE employed by the organization sponsoring the study.
There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
Results Point of Contact
Name/Title | Leonard Weinstock, MD |
---|---|
Organization | Specialists in Gastroenterology, LLC |
Phone | 314-997-0554 ext 102 |
lw@gidoctor.net |
- BP-1
- Leonard Weinstock, MD